EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro cytoprotective and in vivo anti-oral mucositis effects of melatonin and its derivatives

Pramote Mahakunakorn, Pimpichaya Sangchart, Panyada Panyatip iD, Juthamat Ratha iD, Teerasak Damrongrungruang, Aroonsri Priprem, Ploenthip Puthongking

PeerJ · 2024

DOI: 10.7717/peerj.17608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Pramote Mahakunakorn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacognosy and Toxicology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Melatonin, Stomatitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khon Kaen University-National Research Council of Thailand (KKU-NRCT), National Science, Research and Innovation Fund (NSRF), Thailand via the Fundamental Fund (FF) of Khon Kaen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to our preliminary study, melatonin and its N -amide derivatives ( N -(2-(1-4-bromobenzoyl-5-methoxy-1H-indol-3-yl)ethyl)acetamide (BBM) and 4-bromo- N -(2-(5-methoxy-1H-indol-3-yl)ethyl)benzamide (EBM)) inhibited the marker of acute inflammation in tests in vitro and in vivo . The anti-inflammatory agent is intended for the prevention and treatment of chemotherapy-induced toxicity. In this study aimed to evaluate the effect of melatonin and its derivatives on mechanisms related to chemotherapy-induced oral mucositis by in vitro ROS and 5-FU-induced human keratinocyte cells as well as in vivo oral mucositis model. In in vitro H 2 O 2 -induced HaCaT cells, BBM had the highest level of protection (34.57%) at a concentration 50 µM, followed by EBM (26.41%), and melatonin (7.9%). BBM also protected cells against 5-FU-induced to 37.69–27.25% at 12.5–100 µM while EBM was 36.93–29.33% and melatonin was 22.5–11.39%. In in vivo 5-FU-induced oral mucositis in mice, melatonin, BBM, and EBM gel formulations protected tissue damage from 5-FU similar to the standard compound, benzydamine. Moreover, the weight of mice and food consumption recovered more quickly in the BBM group. These findings suggested that it was possible to develop BBM and EBM as new therapeutic agents for the treatment of oral mucositis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninStomatitisAnimalsHumansMiceKeratinocytesFluorouracilMaleReactive Oxygen SpeciesAnti-Inflammatory AgentsAntioxidants

Stichwörter der Autor:innen

5-FluorouracilAmide derivativesChemotherapyCytoprotectiveMelatoninOral mucositis

Substanzen

MelatoninFluorouracilReactive Oxygen SpeciesAnti-Inflammatory AgentsAntioxidants

Autor:innen und Institutionen

  • Division of Pharmacognosy and Toxicology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok, Thailand.
  • Department of Pharmacognosy, Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok, Thailand.
  • Melatonin Research Group, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Oral Biomedical Sciences, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
  • Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand.

ORCID-Profile: Panyada Panyatip, Juthamat Ratha

Förderung

  • Khon Kaen University-National Research Council of Thailand (KKU-NRCT)
  • National Science, Research and Innovation Fund (NSRF), Thailand via the Fundamental Fund (FF) of Khon Kaen University

Zitieren

APA

Mahakunakorn, P., Sangchart, P., Panyatip, P., Ratha, J., Damrongrungruang, T., Priprem, A., & Puthongking, P. (2024). In vitro cytoprotective and in vivo anti-oral mucositis effects of melatonin and its derivatives. PeerJ. https://doi.org/10.7717/peerj.17608

Vancouver

Mahakunakorn P, Sangchart P, Panyatip P, Ratha J, Damrongrungruang T, Priprem A, et al. In vitro cytoprotective and in vivo anti-oral mucositis effects of melatonin and its derivatives. PeerJ. 2024. doi:10.7717/peerj.17608

BibTeX
@article{Mahakunakorn2024,
  author = {Mahakunakorn, Pramote and Sangchart, Pimpichaya and Panyatip, Panyada and Ratha, Juthamat and Damrongrungruang, Teerasak and Priprem, Aroonsri and Puthongking, Ploenthip},
  title = {In vitro cytoprotective and in vivo anti-oral mucositis effects of melatonin and its derivatives},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17608}
}
Kostenlos starten →